128 related articles for article (PubMed ID: 30034611)
1. Identification of
Li L; Lv K; Yang Y; Sun J; Tao Z; Wang A; Wang B; Wang H; Geng Y; Liu M; Guo H; Lu Y
ACS Med Chem Lett; 2018 Jul; 9(7):741-745. PubMed ID: 30034611
[TBL] [Abstract][Full Text] [Related]
2. Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents.
Lv K; You X; Wang B; Wei Z; Chai Y; Wang B; Wang A; Huang G; Liu M; Lu Y
ACS Med Chem Lett; 2017 Jun; 8(6):636-641. PubMed ID: 28626525
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
Wang H; Wang A; Gu J; Fu L; Lv K; Ma C; Tao Z; Wang B; Liu M; Guo H; Lu Y
Eur J Med Chem; 2019 Mar; 165():11-17. PubMed ID: 30654236
[TBL] [Abstract][Full Text] [Related]
4. Identification of benzothiazinones containing 2-benzyl-2,7-diazaspiro[3.5]nonane moieties as new antitubercular agents.
Wang A; Ma C; Chai Y; Liu X; Lv K; Fu L; Wang B; Jia X; Liu M; Lu Y
Eur J Med Chem; 2020 Aug; 200():112409. PubMed ID: 32460114
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents.
Tang J; Wang B; Wu T; Wan J; Tu Z; Njire M; Wan B; Franzblauc SG; Zhang T; Lu X; Ding K
ACS Med Chem Lett; 2015 Jul; 6(7):814-8. PubMed ID: 26191372
[TBL] [Abstract][Full Text] [Related]
6. Identification of
Wu Z; Lu Y; Li L; Zhao R; Wang B; Lv K; Liu M; You X
ACS Med Chem Lett; 2016 Dec; 7(12):1130-1133. PubMed ID: 27994751
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Fluorine-Containing Benzoxazinyl-oxazolidinones for the Treatment of Multidrug Resistant Tuberculosis.
Zhao H; Lu Y; Sheng L; Yuan Z; Wang B; Wang W; Li Y; Ma C; Wang X; Zhang D; Huang H
ACS Med Chem Lett; 2017 May; 8(5):533-537. PubMed ID: 28523106
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and antitubercular activity of novel N-(amino)piperazinyl benzothiazinones with improved safety.
Wang A; Du N; Song H; Zhang Y; Zhong X; Wu J; Xue T; Liu M; Wang B; Lv K; Lu Y
Eur J Med Chem; 2023 Oct; 258():115545. PubMed ID: 37300914
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of nitrofuranyl methyl N-heterocycles derivatives as novel antitubercular agents.
Wang A; Li W; Wang B; Lv K; Wang H; Liu M; Guo H; Lu Y
Future Med Chem; 2018 Sep; 10(17):2059-2068. PubMed ID: 29992836
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and antimycobacterial activity of 3,5-dinitrobenzamide derivatives containing fused ring moieties.
Wang A; Huang G; Wang B; Lv K; Wang H; Tao Z; Liu M; Guo H; Lu Y
Bioorg Med Chem Lett; 2018 Sep; 28(17):2945-2948. PubMed ID: 30006066
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and antimycobacterial activity of less lipophilic Q203 derivatives containing alkaline fused ring moieties.
Wang A; Wang H; Geng Y; Fu L; Gu J; Wang B; Lv K; Liu M; Tao Z; Ma C; Lu Y
Bioorg Med Chem; 2019 Mar; 27(5):813-821. PubMed ID: 30692025
[TBL] [Abstract][Full Text] [Related]
12. Discovery of (3-Benzyl-5-hydroxyphenyl)carbamates as New Antitubercular Agents with Potent In Vitro and In Vivo Efficacy.
Cheng YJ; Liu ZY; Liang HJ; Fang CT; Zhang NN; Zhang TY; Yan M
Molecules; 2019 May; 24(10):. PubMed ID: 31137832
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety.
Lv K; Tao Z; Liu Q; Yang L; Wang B; Wu S; Wang A; Huang M; Liu M; Lu Y
Eur J Med Chem; 2018 May; 151():1-8. PubMed ID: 29601990
[TBL] [Abstract][Full Text] [Related]
14. Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents.
Wang A; Lv K; Tao Z; Gu J; Fu L; Liu M; Wan B; Franzblau SG; Ma C; Ma X; Han B; Wang A; Xu S; Lu Y
Eur J Med Chem; 2019 Nov; 181():111595. PubMed ID: 31408806
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma.
Spaggiari D; Desfontaine V; Cruchon S; Guinchard S; Vocat A; Blattes E; Pitteloud J; Ciullini L; Bardinet C; Ivanyuk A; Makarov V; Ryabova O; Buclin T; Cole ST; Decosterd LA
PLoS One; 2019; 14(5):e0217139. PubMed ID: 31150423
[TBL] [Abstract][Full Text] [Related]
16. Identification of a new series of benzothiazinone derivatives with excellent antitubercular activity and improved pharmacokinetic profiles.
Xiong L; Gao C; Shi YJ; Tao X; Rong J; Liu KL; Peng CT; Wang NY; Lei Q; Zhang YW; Yu LT; Wei YQ
RSC Adv; 2018 Mar; 8(20):11163-11176. PubMed ID: 35541526
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
18. Identification of Pyrazolo[1,5-
Hu X; Wan B; Liu Y; Shen J; Franzblau SG; Zhang T; Ding K; Lu X
ACS Med Chem Lett; 2019 Mar; 10(3):295-299. PubMed ID: 30891129
[TBL] [Abstract][Full Text] [Related]
19. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
Wang A; Lv K; Li L; Liu H; Tao Z; Wang B; Liu M; Ma C; Ma X; Han B; Wang A; Lu Y
Eur J Med Chem; 2019 Sep; 178():715-725. PubMed ID: 31229874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
